This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thomázy, V. A. Articles by Medeiros, L. J. Search for Related Content PubMed PubMed Citation Articles by Thomázy, V. A. Articles by Medeiros, L. J.

JMD 2002, Vol. 4, No. 4
Copyright © 2002 American Society for Investigative Pathology & Association for Molecular Pathology

Determination of Cyclin D1 and CD20 mRNA Levels by Real-Time Quantitative RT-PCR from Archival Tissue Sections of Mantle Cell Lymphoma and Other Non-Hodgkin’s Lymphomas

Vilmos A. Thomázy^*, Rajyalakshmi Luthra, Margaret O. Uthman^*, Peter J.A. Davies and L. Jeffrey Medeiros

From the Departments of Pathology and Laboratory Medicine, * and Integrative Biology and Pharmacology, The University of Texas-Houston Medical School, Houston; and the Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

Cyclin D1 overexpression is a valuable marker for the diagnosis of mantle cell lymphoma (MCL). We used a real-time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) method to quantify levels of cyclin D1, CD20, and cyclophilin A mRNA in manually microdissected, paraffin-embedded tissue sections using an ABI 7700 qRT-PCR system. The study group included 21 cases of MCL and 37 cases of other types of B-cell non-Hodgkin’s lymphoma. Cyclin D1 mRNA copy number was normalized to CD20 and cyclophilin A mRNA and evaluated statistically by analysis of variance. The relative cyclin D1 levels were similar whether normalized to CD20 or cyclophilin A, indicating that CD20 levels are stable and can be used as a B-cell-specific normalizer. Statistically significant differences were found in the median levels of cyclin D1 mRNA (expressed as % CD20 mRNA) among cases of MCL (87.6), small lymphocytic lymphoma (9.9), follicular lymphoma (2.4), diffuse large B-cell lymphoma (5.9), marginal zone B-cell lymphoma (39.8), and Burkitt lymphoma (7.1) (P < 0.05). We conclude that qRT-PCR can be used to quantify cyclin D1 mRNA levels in archival tissue sections. Normalization of cyclin D1 to a B-cell-specific marker more accurately reflects overexpression by MCL than other methods that normalize using constitutively expressed mRNA species.

This article has been cited by other articles:

				T. Carvalho, D. Naydan, T. Nunes, C. Pinto, and M. C. Peleteiro Immunohistochemical Evaluation of Vascular Urinary Bladder Tumors from Cows with Enzootic Hematuria Vet. Pathol., March 1, 2009; 46(2): 211 - 221. [Abstract] [Full Text] [PDF]

				C. D. Jones, K. H. Darnell, R. A. Warnke, and J. L. Zehnder CyclinD1/CyclinD3 Ratio by Real-Time PCR Improves Specificity for the Diagnosis of Mantle Cell Lymphoma J. Mol. Diagn., May 1, 2004; 6(2): 84 - 89. [Abstract] [Full Text] [PDF]

				M. Cronin, M. Pho, D. Dutta, J. C. Stephans, S. Shak, M. C. Kiefer, J. M. Esteban, and J. B. Baker Measurement of Gene Expression in Archival Paraffin-Embedded Tissues: Development and Performance of a 92-Gene Reverse Transcriptase-Polymerase Chain Reaction Assay Am. J. Pathol., January 1, 2004; 164(1): 35 - 42. [Abstract] [Full Text] [PDF]

				J. G. Howe, J. Crouch, D. Cooper, and B. R. Smith Real-Time Quantitative Reverse Transcription-PCR for Cyclin D1 mRNA in Blood, Marrow, and Tissue Specimens for Diagnosis of Mantle Cell Lymphoma Clin. Chem., January 1, 2004; 50(1): 80 - 87. [Abstract] [Full Text] [PDF]